72 related articles for article (PubMed ID: 15648062)
1. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.
Colson P; Henry M; Tivoli N; Gallais H; Gastaut JA; Moreau J; Tamalet C
J Med Virol; 2005 Mar; 75(3):381-90. PubMed ID: 15648062
[TBL] [Abstract][Full Text] [Related]
2. Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
Quiñones-Mateu ME; Tadele M; Parera M; Mas A; Weber J; Rangel HR; Chakraborty B; Clotet B; Domingo E; Menéndez-Arias L; Martínez MA
J Virol; 2002 Oct; 76(20):10546-52. PubMed ID: 12239335
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.
Colson P; Henry M; Tourres C; Lozachmeur D; Gallais H; Gastaut JA; Moreau J; Tamalet C
J Clin Microbiol; 2004 Feb; 42(2):570-7. PubMed ID: 14766818
[TBL] [Abstract][Full Text] [Related]
4. Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.
Gonzales MJ; Wu TD; Taylor J; Belitskaya I; Kantor R; Israelski D; Chou S; Zolopa AR; Fessel WJ; Shafer RW
AIDS; 2003 Apr; 17(6):791-9. PubMed ID: 12660525
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus 1 5'-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations.
Nouhin J; Tzou PL; Rhee SY; Sahoo MK; Pinsky BA; Krupkin M; Puglisi JD; Puglisi EV; Shafer RW
J Gen Virol; 2023 Oct; 104(10):. PubMed ID: 37801004
[TBL] [Abstract][Full Text] [Related]
6. Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.
Fiebig U; Altmann B; Hauser A; Koppe U; Hanke K; Gunsenheimer-Bartmeyer B; Bremer V; Baumgarten A; Bannert N
BMC Infect Dis; 2023 Oct; 23(1):673. PubMed ID: 37817087
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.
Damond F; Brun-Vezinet F; Matheron S; Peytavin G; Campa P; Pueyo S; Mammano F; Lastere S; Farfara I; Simon F; Chene G; Descamps D
J Clin Microbiol; 2005 Jan; 43(1):484-7. PubMed ID: 15635022
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
Bennett DE; Camacho RJ; Otelea D; Kuritzkes DR; Fleury H; Kiuchi M; Heneine W; Kantor R; Jordan MR; Schapiro JM; Vandamme AM; Sandstrom P; Boucher CA; van de Vijver D; Rhee SY; Liu TF; Pillay D; Shafer RW
PLoS One; 2009; 4(3):e4724. PubMed ID: 19266092
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral drug resistance in human immunodeficiency virus type 2.
Ntemgwa ML; d'Aquin Toni T; Brenner BG; Camacho RJ; Wainberg MA
Antimicrob Agents Chemother; 2009 Sep; 53(9):3611-9. PubMed ID: 19470514
[No Abstract] [Full Text] [Related]
10. The "Connection" Between HIV Drug Resistance and RNase H.
Delviks-Frankenberry KA; Nikolenko GN; Pathak VK
Viruses; 2010 Jul; 2(7):1476-1503. PubMed ID: 21088701
[TBL] [Abstract][Full Text] [Related]
11. Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity.
Smith RL; Tan JME; Jonker MJ; Jongejan A; Buissink T; Veldhuijzen S; van Kampen AHC; Brul S; van der Spek H
PLoS One; 2017; 12(11):e0187424. PubMed ID: 29095935
[TBL] [Abstract][Full Text] [Related]
12. HIV reverse transcriptase: structural interpretation of drug resistant genetic variants from India.
Kandathil AJ; Joseph AP; Kannangai R; Srinivasan N; Abraham OC; Pulimood SA; Sridharan G
Bioinformation; 2009 Aug; 4(1):36-45. PubMed ID: 20011151
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 5'-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations.
Nouhin J; Tzou PL; Rhee SY; Sahoo MK; Pinsky BA; Krupkin M; Puglisi JD; Puglisi EV; Shafer RW
medRxiv; 2023 Aug; ():. PubMed ID: 37333388
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.
Chow TW; Raupp M; Reynolds MW; Li S; Kaeser GE; Chun J
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675371
[TBL] [Abstract][Full Text] [Related]
15. Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.
Rajurkar M; Parikh AR; Solovyov A; You E; Kulkarni AS; Chu C; Xu KH; Jaicks C; Taylor MS; Wu C; Alexander KA; Good CR; Szabolcs A; Gerstberger S; Tran AV; Xu N; Ebright RY; Van Seventer EE; Vo KD; Tai EC; Lu C; Joseph-Chazan J; Raabe MJ; Nieman LT; Desai N; Arora KS; Ligorio M; Thapar V; Cohen L; Garden PM; Senussi Y; Zheng H; Allen JN; Blaszkowsky LS; Clark JW; Goyal L; Wo JY; Ryan DP; Corcoran RB; Deshpande V; Rivera MN; Aryee MJ; Hong TS; Berger SL; Walt DR; Burns KH; Park PJ; Greenbaum BD; Ting DT
Cancer Discov; 2022 Jun; 12(6):1462-1481. PubMed ID: 35320348
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds.
Moranguinho I; Taveira N; Bártolo I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982978
[TBL] [Abstract][Full Text] [Related]
17. Novel assays to investigate the mechanisms of latent infection with HIV-2.
Lu MD; Telwatte S; Kumar N; Ferreira F; Martin HA; Kadiyala GN; Wedrychowski A; Moron-Lopez S; Chen TH; Goecker EA; Coombs RW; Lu CM; Wong JK; Tsibris A; Yukl SA
PLoS One; 2022; 17(4):e0267402. PubMed ID: 35476802
[TBL] [Abstract][Full Text] [Related]
18. Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
Tzou PL; Descamps D; Rhee SY; Raugi DN; Charpentier C; Taveira N; Smith RA; Soriano V; de Mendoza C; Holmes SP; Gottlieb GS; Shafer RW
J Infect Dis; 2020 Jun; 221(12):1962-1972. PubMed ID: 31965175
[TBL] [Abstract][Full Text] [Related]
19. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
Álvarez M; Nevot M; Mendieta J; Martínez MA; Menéndez-Arias L
J Biol Chem; 2018 Feb; 293(7):2247-2259. PubMed ID: 29275329
[TBL] [Abstract][Full Text] [Related]
20. MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.
Wu VH; Smith RA; Masoum S; Raugi DN; Ba S; Seydi M; Grobler JA; Gottlieb GS;
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
